Loading…
Aditxt, Inc. is projected to decline to $0.00268 by 2027, a -11% move from its current price of $0.0030. ADTX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.002635 | $0.003003 | $0.003423 | +0.10% |
| Aug 6 | $0.002498 | $0.003006 | $0.003617 | +0.20% |
| Aug 7 | $0.002399 | $0.003009 | $0.003774 | +0.30% |
| Aug 8 | $0.002318 | $0.003012 | $0.003913 | +0.39% |
| Aug 9 | $0.00225 | $0.003015 | $0.00404 | +0.49% |
| Aug 10 | $0.00219 | $0.003018 | $0.004158 | +0.59% |
| Aug 11 | $0.002137 | $0.003021 | $0.00427 | +0.69% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.002137 | $0.003021 | $0.00427 | +0.69% |
| Week 2 | $0.001864 | $0.003042 | $0.004963 | +1.39% |
| Week 3 | $0.001681 | $0.003063 | $0.005579 | +2.09% |
| Week 4 | $0.001543 | $0.003084 | $0.006163 | +2.79% |
| Week 5 | $0.001432 | $0.003105 | $0.006734 | +3.51% |
| Week 6 | $0.001339 | $0.003127 | $0.007301 | +4.22% |
| Week 7 | $0.00126 | $0.003148 | $0.007868 | +4.94% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aditxt, Inc. is a healthcare company focused on discovery and development of biopharmaceutical products. It develops AditxtScore and FlowSpot to help individuals understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system.
It also pursues Apoptotic DNA Immunotherapy, a nucleic acid-based technology that mimics the way the body naturally induces tolerance to its tissues, and it develops ADI-100 for skin grafting, psoriasis, and type-1 diabetes.
The company has a license agreement with Loma Linda University and Leland Stanford Junior University. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California; it was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021.
Aditxt, Inc. (ADTX) trades as a healthcare stock with a current price of $0.0030 and a market capitalization of $2.99M, ranking at 5202. The stock sits in the low-price tier within the market, underscoring a micro-cap profile.
The near-term outlook is subdued, with the 2026 forecast showing a minimal uptick from the current level and a neutral stance overall. Longer-term projections indicate the potential for upside, though with a history of volatility and alternating bullish/bearish phases across the forecast horizon.
Looking further out, the 2040 and 2050 projections show more meaningful upside, with the average price rising and exceptionally higher maxima, implying a wide potential range from downside to substantial gains in the far future.
A major floor 33.3% below — a decisive break under it would weaken the trend.
The nearest floor, 33.3% below — buyers have tended to step in here.
The nearest ceiling, 1300.0% above — a clean break opens room to run.
A major ceiling 881000.0% above — clearing it would confirm fresh momentum.
Key ADTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ADTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0030 | Sell | $0.003092 | Sell |
| MA 10 | $0.0033 | Sell | $0.003488 | Sell |
| MA 20 | $0.00345 | Sell | $0.0461 | Sell |
| MA 50 | $0.0931 | Sell | $16.64 | Sell |
| MA 100 | $9.21 | Sell | $38,387.65 | Sell |
| MA 200 | $637.38 | Sell | $24,729,112.39 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 14.11 | Buy |
| Stoch RSI (14) | 88.90 | Sell |
| CCI (20) | -60.61 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.10 | Buy |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -9.64 | Sell |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 45.64 | Neutral |
| Momentum (10) | 0.00 | Neutral |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 0.00 | Buy |
| ADX (14) | 72.04 | Sell |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is mixed with a neutral overall sentiment. RSI14 is 10, suggesting oversold conditions, while the stock trades well below both moving averages listed (SMA50 is $0.226 and SMA200 is $941.87).
Price remains anchored near a support level at $0.0020 and faces a resistance at $0.042. The 30-day range spans from $0.0007174 to $0.0125, signaling substantial intra-month volatility. The annualized volatility sits at 400%, highlighting the wide swings around the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.0020 | $0.0030 | $0.004251 | 0% | Neutral | |
| $0.001953 | $0.00268 | $0.003974 | -11% | Neutral | |
| $0.001745 | $0.002547 | $0.00403 | -15% | Bearish | |
| $0.001633 | $0.002512 | $0.004175 | -16% | Bearish | |
| $0.001587 | $0.00256 | $0.004432 | -15% | Neutral | |
| $0.002029 | $0.00342 | $0.006132 | +14% | Neutral | |
| $0.002116 | $0.003721 | $0.006881 | +24% | Bullish | |
| $0.002022 | $0.003703 | $0.007039 | +23% | Bullish | |
| $0.001699 | $0.003237 | $0.006309 | +8% | Neutral | |
| $0.001368 | $0.00271 | $0.005405 | -10% | Neutral | |
| $0.001901 | $0.004224 | $0.009262 | +41% | Bullish | |
| $0.004215 | $0.009368 | $0.0215 | +212% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.0020 | $0.0030 | $0.003833 | +0.00% |
| September 2026 | $0.002738 | $0.003328 | $0.00422 | +10.93% |
| October 2026 | $0.002663 | $0.003282 | $0.004247 | -1.38% |
| November 2026 | $0.002502 | $0.003119 | $0.004102 | -4.96% |
| December 2026 | $0.002529 | $0.003186 | $0.004251 | +2.14% |
Click any year to see its month-by-month ADTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ADTX could reach as high as $0.004251, with a base case around $0.0030 and support toward $0.0020 — roughly 0% from $0.0030. Price action looks broadly range-bound.
Expect ADTX to range from $0.001953 to $0.003974 through 2027. The $0.00268 average target implies a -11% move from current prices. That is -11% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The ADTX price prediction for 2028 points to an average of $0.002547 (low $0.001745, high $0.00403) — a potential decline of -15% on today's $0.0030. A cyclical pullback looks likely — prices rarely move in a straight line.
In 2029, ADTX is projected to trade between $0.001633 and $0.004175, averaging $0.002512 — a potential decline of -16% from today's $0.0030. That is -1% versus the projected 2028 average. Expect choppier, lower action through this leg of the cycle.
Aditxt, Inc.'s 2030 outlook centres on $0.00256, within a $0.001587 to $0.004432 range. That is up +2% on the projected 2029 average. That marks a -15% change versus current levels. Price action looks broadly range-bound.
By 2031, ADTX could reach as high as $0.006132, with a base case around $0.00342 and support toward $0.002029 — roughly +14% from $0.0030. A consolidation phase looks the most probable path here.
Expect ADTX to range from $0.002116 to $0.006881 through 2032. The $0.003721 average target implies a +24% move from current prices. That is up +9% on the projected 2031 average. Momentum favours further upside here.
The ADTX price prediction for 2033 points to an average of $0.003703 (low $0.002022, high $0.007039) — a potential gain of +23% on today's $0.0030. Buyers look set to stay in control over this stretch.
In 2034, ADTX is projected to trade between $0.001699 and $0.006309, averaging $0.003237 — a potential gain of +8% from today's $0.0030. That is -13% versus the projected 2033 average. Price action looks broadly range-bound.
Aditxt, Inc.'s 2035 outlook centres on $0.00271, within a $0.001368 to $0.005405 range. That is -16% versus the projected 2034 average. That marks a -10% change versus current levels. A consolidation phase looks the most probable path here.
By 2040, ADTX could reach as high as $0.009262, with a base case around $0.004224 and support toward $0.001901 — roughly +41% from $0.0030. Momentum favours further upside here.
Expect ADTX to range from $0.004215 to $0.0215 through 2050. The $0.009368 average target implies a +212% move from current prices. That is up +122% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ADTX today (≈ 333,333.333333 ADTX) could be worth
$3,122.58
+$2,122.58 (+212%) by 2050 · US Dollar
Based on the average projected ADTX price of $0.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ADTXwould be worth at today's price.
$1,000 invested in ADTX on Jul 31, 2025 (≈ 0.037587 ADTX) would be worth
$0
-$1,000 (-100.0%) today · 0.00× · US Dollar
Based on a ADTX entry price of $26,604.72 vs. today's $0.003.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.004 | $750 | -25.0% |
| 1 month ago | $0.005 | $600 | -40.0% |
| 3 months ago | $5.26 | $0.57 | -99.9% |
| 6 months ago | $172.15 | $0.02 | -100.0% |
| 1 year ago | $26,604.72 | $0 | -100.0% |
| All time (5.0y) ago | $1,034,899,226,624 | $0 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ADTX forecast.
Our base-case forecast reaches $0.0060 around 2050.
Implied market cap at $0.0060: $5.99M
The year-by-year forecast shows a pattern of limited near-term upside followed by sporadic bullish momentum in the mid-to-late horizon. For 2026, the avg is $0.0030 with a min of $0.0020 and a max of $0.004303, ROI 0%, sentiment NEUTRAL.
In 2030, the avg drops to $0.002517 (min $0.001559, max $0.004361) with a negative ROI of -16.1% and a BEARISH sentiment.
The outlook improves into 2032-2033 with bullish signals: 2032 avg $0.003796 (max $0.007023, ROI 26.6, sentiment BULLISH) and 2033 avg $0.003634 (max $0.00691, ROI 21.1, sentiment BULLISH).
There is continued volatility through 2034-2035 (2034 avg $0.003212, ROI 7.1, sentiment NEUTRAL; 2035 avg $0.002776, ROI -7.5, sentiment NEUTRAL).
The horizon shows stronger upside later, with 2040 avg $0.004255 (max $0.009333, ROI 41.8, sentiment BULLISH) and 2050 avg $0.009474 (max $0.0218, ROI 215.8, sentiment BULLISH).
Overall, these are estimates, not guarantees, and carry substantial uncertainty. The forecast suggests potential long-term upside but with notable periods of downside risk and volatility.
Tap a question to reveal the answer.
The 2030 forecast lists a min of $0.001559, an average of $0.002517, and a max of $0.004361, with a projected ROI of -16.1% and a BEARISH sentiment.
For 2026, the avg forecast is $0.0030 with a min of $0.0020 and a max of $0.004303, ROI 0% and sentiment NEUTRAL, indicating a flat near-term outlook in the model’s terms.
The 2050 forecast shows a max price of $0.0218 with an avg of $0.009474 (ROI 215.8, sentiment BULLISH). Specifically, reaching $0.01 would be supported by the 2050 max, while the 2040 max is $0.009333, which is below $0.01.
Current price is $0.0030 and market cap is $2.99M.
RSI14 is 10 with neutral sentiment; SMA50 is $0.226 and SMA200 is $941.87. The stock has support at $0.0020 and resistance at $0.042, with a 30-day range from $0.0007174 to $0.0125 and annualized volatility of 400%.
Aditxt, Inc. Community Discussion
0Share your Aditxt, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.